A BILL 
To amend the Public Health Service Act to provide for 
cooperative governing of individual health insurance coverage. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. COOPERATIVE GOVERNING OF INDIVIDUAL 
3
HEALTH INSURANCE COVERAGE. 
4
(a) IN GENERAL.—Title XXVII of the Public Health 
5
Service Act (42 U.S.C. 300gg et seq.) is amended by add-
6
ing at the end the following new part: 
7
23:00 Jan 11, 2021
H32
2 
•HR 32 IH
‘‘PART D—COOPERATIVE GOVERNING OF 
1
INDIVIDUAL HEALTH INSURANCE COVERAGE 
2
‘‘SEC. 2795. DEFINITIONS. 
3
‘‘In this part: 
4
‘‘(1) PRIMARY
STATE.—The term ‘primary 
5
State’ means, with respect to individual health insur-
6
ance coverage offered by a health insurance issuer, 
7
the State designated by the issuer as the State 
8
whose covered laws shall govern the health insurance 
9
issuer in the sale of such coverage under this part. 
10
An issuer, with respect to a particular policy, may 
11
only designate one such State as its primary State 
12
with respect to all such coverage it offers. Such an 
13
issuer may not change the designated primary State 
14
with respect to individual health insurance coverage 
15
once the policy is issued, except that such a change 
16
may be made upon renewal of the policy. With re-
17
spect to such designated State, the issuer is deemed 
18
to be doing business in that State. 
19
‘‘(2) SECONDARY STATE.—The term ‘secondary 
20
State’ means, with respect to individual health insur-
21
ance coverage offered by a health insurance issuer, 
22
any State that is not the primary State. In the case 
23
of a health insurance issuer that is selling a policy 
24
in, or to a resident of, a secondary State, the issuer 
25
23:00 Jan 11, 2021
H32
3 
•HR 32 IH
is deemed to be doing business in that secondary 
1
State. 
2
‘‘(3) HEALTH INSURANCE ISSUER.—The term 
3
‘health insurance issuer’ has the meaning given such 
4
term in section 2791(b)(2), except that such an 
5
issuer must be licensed in the primary State and be 
6
qualified to sell individual health insurance coverage 
7
in that State. 
8
‘‘(4) INDIVIDUAL
HEALTH
INSURANCE
COV-
9
ERAGE.—The term ‘individual health insurance cov-
10
erage’ means health insurance coverage offered in 
11
the individual market, as defined in section 
12
2791(e)(1). 
13
‘‘(5) APPLICABLE
STATE
AUTHORITY.—The 
14
term ‘applicable State authority’ means, with respect 
15
to a health insurance issuer in a State, the State in-
16
surance commissioner or official or officials des-
17
ignated by the State to enforce the requirements of 
18
this title for the State with respect to the issuer. 
19
‘‘(6) HAZARDOUS FINANCIAL CONDITION.—The 
20
term ‘hazardous financial condition’ means that, 
21
based on its present or reasonably anticipated finan-
22
cial condition, a health insurance issuer is unlikely 
23
to be able— 
24
23:00 Jan 11, 2021
H32
4 
•HR 32 IH
‘‘(A) to meet obligations to policyholders 
1
with respect to known claims and reasonably 
2
anticipated claims; or 
3
‘‘(B) to pay other obligations in the normal 
4
course of business. 
5
‘‘(7) COVERED LAWS.— 
6
‘‘(A) IN
GENERAL.—The term ‘covered 
7
laws’ means the laws, rules, regulations, agree-
8
ments, and orders governing the insurance busi-
9
ness pertaining to— 
10
‘‘(i) individual health insurance cov-
11
erage issued by a health insurance issuer; 
12
‘‘(ii) the offer, sale, rating (including 
13
medical 
underwriting), 
renewal, 
and 
14
issuance of individual health insurance cov-
15
erage to an individual; 
16
‘‘(iii) the provision to an individual in 
17
relation to individual health insurance cov-
18
erage of health care and insurance related 
19
services; 
20
‘‘(iv) the provision to an individual in 
21
relation to individual health insurance cov-
22
erage of management, operations, and in-
23
vestment activities of a health insurance 
24
issuer; and 
25
23:00 Jan 11, 2021
H32
5 
•HR 32 IH
‘‘(v) the provision to an individual in 
1
relation to individual health insurance cov-
2
erage of loss control and claims adminis-
3
tration for a health insurance issuer with 
4
respect to liability for which the issuer pro-
5
vides insurance. 
6
‘‘(B) EXCEPTION.—Such term does not in-
7
clude any law, rule, regulation, agreement, or 
8
order governing the use of care or cost manage-
9
ment techniques, including any requirement re-
10
lated to provider contracting, network access or 
11
adequacy, health care data collection, or quality 
12
assurance. 
13
‘‘(8) STATE.—The term ‘State’ means the 50 
14
States and includes the District of Columbia, Puerto 
15
Rico, the Virgin Islands, Guam, American Samoa, 
16
and the Northern Mariana Islands. 
17
‘‘(9) UNFAIR
CLAIMS
SETTLEMENT
PRAC-
18
TICES.—The term ‘unfair claims settlement prac-
19
tices’ means only the following practices: 
20
‘‘(A) Knowingly misrepresenting to claim-
21
ants and insured individuals relevant facts or 
22
policy provisions relating to coverage at issue. 
23
23:00 Jan 11, 2021
H32
6 
•HR 32 IH
‘‘(B) Failing to acknowledge with reason-
1
able promptness pertinent communications with 
2
respect to claims arising under policies. 
3
‘‘(C) Failing to adopt and implement rea-
4
sonable standards for the prompt investigation 
5
and settlement of claims arising under policies. 
6
‘‘(D) Failing to effectuate prompt, fair, 
7
and equitable settlement of claims submitted in 
8
which liability has become reasonably clear. 
9
‘‘(E) Refusing to pay claims without con-
10
ducting a reasonable investigation. 
11
‘‘(F) Failing to affirm or deny coverage of 
12
claims within a reasonable period of time after 
13
having completed an investigation related to 
14
those claims. 
15
‘‘(G) A pattern or practice of compelling 
16
insured individuals or their beneficiaries to in-
17
stitute suits to recover amounts due under its 
18
policies by offering substantially less than the 
19
amounts ultimately recovered in suits brought 
20
by them. 
21
‘‘(H) A pattern or practice of attempting 
22
to settle or settling claims for less than the 
23
amount that a reasonable person would believe 
24
the insured individual or his or her beneficiary 
25
23:00 Jan 11, 2021
H32
7 
•HR 32 IH
was entitled by reference to written or printed 
1
advertising material accompanying or made 
2
part of an application. 
3
‘‘(I) Attempting to settle or settling claims 
4
on the basis of an application that was materi-
5
ally altered without notice to, or knowledge or 
6
consent of, the insured. 
7
‘‘(J) Failing to provide forms necessary to 
8
present claims within 15 calendar days of a re-
9
quest with reasonable explanations regarding 
10
their use. 
11
‘‘(K) Attempting to cancel a policy in less 
12
time than that prescribed in the policy or by the 
13
law of the primary State. 
14
‘‘(10) FRAUD AND ABUSE.—The term ‘fraud 
15
and abuse’ means an act or omission committed by 
16
a person who, knowingly and with intent to defraud, 
17
commits, or conceals any material information con-
18
cerning, one or more of the following: 
19
‘‘(A) Presenting, causing to be presented 
20
or preparing with knowledge or belief that it 
21
will be presented to or by an insurer, a rein-
22
surer, broker or its agent, false information as 
23
part of, in support of or concerning a fact ma-
24
terial to one or more of the following: 
25
23:00 Jan 11, 2021
H32
8 
•HR 32 IH
‘‘(i) An application for the issuance or 
1
renewal of an insurance policy or reinsur-
2
ance contract. 
3
‘‘(ii) The rating of an insurance policy 
4
or reinsurance contract. 
5
‘‘(iii) A claim for payment or benefit 
6
pursuant to an insurance policy or reinsur-
7
ance contract. 
8
‘‘(iv) Premiums paid on an insurance 
9
policy or reinsurance contract. 
10
‘‘(v) Payments made in accordance 
11
with the terms of an insurance policy or 
12
reinsurance contract. 
13
‘‘(vi) A document filed with the com-
14
missioner or the chief insurance regulatory 
15
official of another jurisdiction. 
16
‘‘(vii) The financial condition of an in-
17
surer or reinsurer. 
18
‘‘(viii) The formation, acquisition, 
19
merger, 
reconsolidation, 
dissolution 
or 
20
withdrawal from one or more lines of in-
21
surance or reinsurance in all or part of a 
22
State by an insurer or reinsurer. 
23
‘‘(ix) The issuance of written evidence 
24
of insurance. 
25
23:00 Jan 11, 2021
H32
9 
•HR 32 IH
‘‘(x) The reinstatement of an insur-
1
ance policy. 
2
‘‘(B) Solicitation or acceptance of new or 
3
renewal insurance risks on behalf of an insurer, 
4
reinsurer, or other person engaged in the busi-
5
ness of insurance by a person who knows or 
6
should know that the insurer or other person 
7
responsible for the risk is insolvent at the time 
8
of the transaction. 
9
‘‘(C) Transaction of the business of insur-
10
ance in violation of laws requiring a license, cer-
11
tificate of authority or other legal authority for 
12
the transaction of the business of insurance. 
13
‘‘(D) Attempt to commit, aiding or abet-
14
ting in the commission of, or conspiracy to com-
15
mit the acts or omissions specified in this para-
16
graph. 
17
‘‘SEC. 2796. APPLICATION OF LAW. 
18
‘‘(a) IN GENERAL.—The covered laws of the primary 
19
State shall apply to individual health insurance coverage 
20
offered by a health insurance issuer in the primary State 
21
and in any secondary State, but only if the coverage and 
22
issuer comply with the conditions of this section with re-
23
spect to the offering of coverage in any secondary State. 
24
23:00 Jan 11, 2021
H32
10 
•HR 32 IH
‘‘(b) EXEMPTIONS FROM COVERED LAWS IN A SEC-
1
ONDARY STATE.—Except as provided in this section, a 
2
health insurance issuer with respect to its offer, sale, rat-
3
ing (including medical underwriting), renewal, and 
4
issuance of individual health insurance coverage in any 
5
secondary State is exempt from any covered laws of the 
6
secondary State (and any rules, regulations, agreements, 
7
or orders sought or issued by such State under or related 
8
to such covered laws) to the extent that such laws would— 
9
‘‘(1) make unlawful, or regulate, directly or in-
10
directly, the operation of the health insurance issuer 
11
operating in the secondary State, except that any 
12
secondary State may require such an issuer— 
13
‘‘(A) to pay, on a nondiscriminatory basis, 
14
applicable premium and other taxes (including 
15
high risk pool assessments) which are levied on 
16
insurers and surplus lines insurers, brokers, or 
17
policyholders under the laws of the State; 
18
‘‘(B) to register with and designate the 
19
State insurance commissioner as its agent solely 
20
for the purpose of receiving service of legal doc-
21
uments or process; 
22
‘‘(C) to submit to an examination of its fi-
23
nancial condition by the State insurance com-
24
missioner in any State in which the issuer is 
25
23:00 Jan 11, 2021
H32
11 
•HR 32 IH
doing business to determine the issuer’s finan-
1
cial condition, if— 
2
‘‘(i) the State insurance commissioner 
3
of the primary State has not done an ex-
4
amination within the period recommended 
5
by the National Association of Insurance 
6
Commissioners; and 
7
‘‘(ii) any such examination is con-
8
ducted in accordance with the examiners’ 
9
handbook of the National Association of 
10
Insurance Commissioners and is coordi-
11
nated to avoid unjustified duplication and 
12
unjustified repetition; 
13
‘‘(D) to comply with a lawful order 
14
issued— 
15
‘‘(i) in a delinquency proceeding com-
16
menced by the State insurance commis-
17
sioner if there has been a finding of finan-
18
cial impairment under subparagraph (C); 
19
or 
20
‘‘(ii) in a voluntary dissolution pro-
21
ceeding; 
22
‘‘(E) to comply with an injunction issued 
23
by a court of competent jurisdiction, upon a pe-
24
tition by the State insurance commissioner al-
25
23:00 Jan 11, 2021
H32
12 
•HR 32 IH
leging that the issuer is in hazardous financial 
1
condition; 
2
‘‘(F) to participate, on a nondiscriminatory 
3
basis, in any insurance insolvency guaranty as-
4
sociation or similar association to which a 
5
health insurance issuer in the State is required 
6
to belong; 
7
‘‘(G) to comply with any State law regard-
8
ing fraud and abuse (as defined in section 
9
2795(10)), except that if the State seeks an in-
10
junction regarding the conduct described in this 
11
subparagraph, such injunction must be obtained 
12
from a court of competent jurisdiction; 
13
‘‘(H) to comply with any State law regard-
14
ing unfair claims settlement practices (as de-
15
fined in section 2795(9)); or 
16
‘‘(I) to comply with the applicable require-
17
ments for independent review under section 
18
2798 with respect to coverage offered in the 
19
State; 
20
‘‘(2) require any individual health insurance 
21
coverage issued by the issuer to be countersigned by 
22
an insurance agent or broker residing in that Sec-
23
ondary State; or 
24
23:00 Jan 11, 2021
H32
13 
•HR 32 IH
‘‘(3) otherwise discriminate against the issuer 
1
issuing insurance in both the primary State and in 
2
any secondary State. 
3
‘‘(c) CLEAR
AND CONSPICUOUS DISCLOSURE.—A 
4
health insurance issuer shall provide the following notice, 
5
in 12-point bold type, in any insurance coverage offered 
6
in a secondary State under this part by such a health in-
7
surance issuer and at renewal of the policy, with the 5 
8
blank spaces therein being appropriately filled with the 
9
name of the health insurance issuer, the name of primary 
10
State, the name of the secondary State, the name of the 
11
secondary State, and the name of the secondary State, re-
12
spectively, for the coverage concerned: 
13
‘‘ ‘NOTICE 
14
‘‘ ‘This policy is issued by lllll and is gov-
15
erned by the laws and regulations of the State of 
16
lllll, and it has met all the laws of that State as 
17
determined by that State’s Department of Insurance. This 
18
policy may be less expensive than others because it is not 
19
subject to all of the insurance laws and regulations of the 
20
State of lllll, including coverage of some services 
21
or benefits mandated by the law of the State of 
22
lllll. Additionally, this policy is not subject to all 
23
of the consumer protection laws or restrictions on rate 
24
changes of the State of lllll. As with all insurance 
25
23:00 Jan 11, 2021
H32
14 
•HR 32 IH
products, before purchasing this policy, you should care-
1
fully review the policy and determine what health care 
2
services the policy covers and what benefits it provides, 
3
including any exclusions, limitations, or conditions for 
4
such services or benefits.’. 
5
‘‘(d) PROHIBITION ON CERTAIN RECLASSIFICATIONS 
6
AND PREMIUM INCREASES.— 
7
‘‘(1) IN GENERAL.—For purposes of this sec-
8
tion, a health insurance issuer that provides indi-
9
vidual health insurance coverage to an individual 
10
under this part in a primary or secondary State may 
11
not upon renewal— 
12
‘‘(A) move or reclassify the individual in-
13
sured under the health insurance coverage from 
14
the class such individual is in at the time of 
15
issue of the contract based on the health status- 
16
related factors of the individual; or 
17
‘‘(B) increase the premiums assessed the 
18
individual for such coverage based on a health 
19
status-related factor or change of a health sta-
20
tus-related factor or the past or prospective 
21
claim experience of the insured individual. 
22
‘‘(2) CONSTRUCTION.—Nothing in paragraph 
23
(1) shall be construed to prohibit a health insurance 
24
issuer— 
25
23:00 Jan 11, 2021
H32
15 
•HR 32 IH
‘‘(A) from terminating or discontinuing 
1
coverage or a class of coverage in accordance 
2
with subsections (b) and (c) of section 2742; 
3
‘‘(B) from raising premium rates for all 
4
policy holders within a class based on claims ex-
5
perience; 
6
‘‘(C) from changing premiums or offering 
7
discounted premiums to individuals who engage 
8
in wellness activities at intervals prescribed by 
9
the issuer, if such premium changes or incen-
10
tives— 
11
‘‘(i) are disclosed to the consumer in 
12
the insurance contract; 
13
‘‘(ii) are based on specific wellness ac-
14
tivities that are not applicable to all indi-
15
viduals; and 
16
‘‘(iii) are not obtainable by all individ-
17
uals to whom coverage is offered; 
18
‘‘(D) from reinstating lapsed coverage; or 
19
‘‘(E) from retroactively adjusting the rates 
20
charged an insured individual if the initial rates 
21
were set based on material misrepresentation by 
22
the individual at the time of issue. 
23
‘‘(e) PRIOR OFFERING
OF POLICY
IN PRIMARY 
24
STATE.—A health insurance issuer may not offer for sale 
25
23:00 Jan 11, 2021
H32
16 
•HR 32 IH
individual health insurance coverage in a secondary State 
1
unless that coverage is currently offered for sale in the 
2
primary State. 
3
‘‘(f) LICENSING
OF AGENTS
OR BROKERS
FOR 
4
HEALTH INSURANCE ISSUERS.—Any State may require 
5
that a person acting, or offering to act, as an agent or 
6
broker for a health insurance issuer with respect to the 
7
offering of individual health insurance coverage obtain a 
8
license from that State, with commissions or other com-
9
pensation subject to the provisions of the laws of that 
10
State, except that a State may not impose any qualifica-
11
tion or requirement which discriminates against a non-
12
resident agent or broker. 
13
‘‘(g) DOCUMENTS FOR SUBMISSION TO STATE IN-
14
SURANCE COMMISSIONER.—Each health insurance issuer 
15
issuing individual health insurance coverage in both pri-
16
mary and secondary States shall submit— 
17
‘‘(1) to the insurance commissioner of each 
18
State in which it intends to offer such coverage, be-
19
fore it may offer individual health insurance cov-
20
erage in such State— 
21
‘‘(A) a copy of the plan of operation or fea-
22
sibility study or any similar statement of the 
23
policy being offered and its coverage (which 
24
23:00 Jan 11, 2021
H32
17 
•HR 32 IH
shall include the name of its primary State and 
1
its principal place of business); 
2
‘‘(B) written notice of any change in its 
3
designation of its primary State; and 
4
‘‘(C) written notice from the issuer of the 
5
issuer’s compliance with all the laws of the pri-
6
mary State; and 
7
‘‘(2) to the insurance commissioner of each sec-
8
ondary State in which it offers individual health in-
9
surance coverage, a copy of the issuer’s quarterly fi-
10
nancial statement submitted to the primary State, 
11
which statement shall be certified by an independent 
12
public accountant and contain a statement of opin-
13
ion on loss and loss adjustment expense reserves 
14
made by— 
15
‘‘(A) a member of the American Academy 
16
of Actuaries; or 
17
‘‘(B) a qualified loss reserve specialist. 
18
‘‘(h) POWER OF COURTS TO ENJOIN CONDUCT.— 
19
Nothing in this section shall be construed to affect the 
20
authority of any Federal or State court to enjoin— 
21
‘‘(1) the solicitation or sale of individual health 
22
insurance coverage by a health insurance issuer to 
23
any person or group who is not eligible for such in-
24
surance; or 
25
23:00 Jan 11, 2021
H32
18 
•HR 32 IH
‘‘(2) the solicitation or sale of individual health 
1
insurance coverage that violates the requirements of 
2
the law of a secondary State which are described in 
3
subparagraphs 
(A) 
through 
(H) 
of 
section 
4
2796(b)(1). 
5
‘‘(i) POWER OF SECONDARY STATES TO TAKE AD-
6
MINISTRATIVE ACTION.—Nothing in this section shall be 
7
construed to affect the authority of any State to enjoin 
8
conduct in violation of that State’s laws described in sec-
9
tion 2796(b)(1). 
10
‘‘(j) STATE POWERS TO ENFORCE STATE LAWS.— 
11
‘‘(1) IN GENERAL.—Subject to the provisions of 
12
subsection (b)(1)(G) (relating to injunctions) and 
13
paragraph (2), nothing in this section shall be con-
14
strued to affect the authority of any State to make 
15
use of any of its powers to enforce the laws of such 
16
State with respect to which a health insurance issuer 
17
is not exempt under subsection (b). 
18
‘‘(2) COURTS OF COMPETENT JURISDICTION.— 
19
If a State seeks an injunction regarding the conduct 
20
described in paragraphs (1) and (2) of subsection 
21
(h), such injunction must be obtained from a Fed-
22
eral or State court of competent jurisdiction. 
23
23:00 Jan 11, 2021
H32
19 
•HR 32 IH
‘‘(k) STATES’ AUTHORITY TO SUE.—Nothing in this 
1
section shall affect the authority of any State to bring ac-
2
tion in any Federal or State court. 
3
‘‘(l) GENERALLY APPLICABLE LAWS.—Nothing in 
4
this section shall be construed to affect the applicability 
5
of State laws generally applicable to persons or corpora-
6
tions. 
7
‘‘(m) GUARANTEED AVAILABILITY OF COVERAGE TO 
8
HIPAA ELIGIBLE INDIVIDUALS.—To the extent that a 
9
health insurance issuer is offering coverage in a primary 
10
State that does not accommodate residents of secondary 
11
States or does not provide a working mechanism for resi-
12
dents of a secondary State, and the issuer is offering cov-
13
erage under this part in such secondary State which has 
14
not adopted a qualified high risk pool as its acceptable 
15
alternative mechanism (as defined in section 2744(c)(2)), 
16
the issuer shall, with respect to any individual health in-
17
surance coverage offered in a secondary State under this 
18
part, comply with the guaranteed availability requirements 
19
for eligible individuals in section 2741. 
20
‘‘SEC. 2797. PRIMARY STATE MUST MEET FEDERAL FLOOR 
21
BEFORE ISSUER MAY SELL INTO SECONDARY 
22
STATES. 
23
‘‘A health insurance issuer may not offer, sell, or 
24
issue individual health insurance coverage in a secondary 
25
23:00 Jan 11, 2021
H32
20 
•HR 32 IH
State if the State insurance commissioner does not use 
1
a risk-based capital formula for the determination of cap-
2
ital and surplus requirements for all health insurance 
3
issuers. 
4
‘‘SEC. 2798. INDEPENDENT EXTERNAL APPEALS PROCE-
5
DURES. 
6
‘‘(a) RIGHT TO EXTERNAL APPEAL.—A health insur-
7
ance issuer may not offer, sell, or issue individual health 
8
insurance coverage in a secondary State under the provi-
9
sions of this title unless— 
10
‘‘(1) both the secondary State and the primary 
11
State have legislation or regulations in place estab-
12
lishing an independent review process for individuals 
13
who are covered by individual health insurance cov-
14
erage; or 
15
‘‘(2) in any case in which the requirements of 
16
subparagraph (A) are not met with respect to the ei-
17
ther of such States, the issuer provides an inde-
18
pendent review mechanism substantially identical (as 
19
determined by the applicable State authority of such 
20
State) to that prescribed in the ‘Health Carrier Ex-
21
ternal Review Model Act’ of the National Association 
22
of Insurance Commissioners for all individuals who 
23
purchase insurance coverage under the terms of this 
24
part, except that, under such mechanism, the review 
25
23:00 Jan 11, 2021
H32
21 
•HR 32 IH
is conducted by an independent medical reviewer, or 
1
a panel of such reviewers, with respect to whom the 
2
requirements of subsection (b) are met. 
3
‘‘(b) QUALIFICATIONS OF INDEPENDENT MEDICAL 
4
REVIEWERS.—In the case of any independent review 
5
mechanism referred to in subsection (a)(2)— 
6
‘‘(1) IN GENERAL.—In referring a denial of a 
7
claim to an independent medical reviewer, or to any 
8
panel of such reviewers, to conduct independent 
9
medical review, the issuer shall ensure that— 
10
‘‘(A) each independent medical reviewer 
11
meets the qualifications described in paragraphs 
12
(2) and (3); 
13
‘‘(B) with respect to each review, each re-
14
viewer meets the requirements of paragraph (4) 
15
and the reviewer, or at least 1 reviewer on the 
16
panel, meets the requirements described in 
17
paragraph (5); and 
18
‘‘(C) compensation provided by the issuer 
19
to each reviewer is consistent with paragraph 
20
(6). 
21
‘‘(2) LICENSURE AND EXPERTISE.—Each inde-
22
pendent medical reviewer shall be a physician 
23
(allopathic or osteopathic) or health care profes-
24
sional who— 
25
23:00 Jan 11, 2021
H32
22 
•HR 32 IH
‘‘(A) is appropriately credentialed or li-
1
censed in one or more States to deliver health 
2
care services; and 
3
‘‘(B) typically treats the condition, makes 
4
the diagnosis, or provides the type of treatment 
5
under review. 
6
‘‘(3) INDEPENDENCE.— 
7
‘‘(A) IN
GENERAL.—Subject to subpara-
8
graph (B), each independent medical reviewer 
9
in a case shall— 
10
‘‘(i) not be a related party (as defined 
11
in paragraph (7)); 
12
‘‘(ii) not have a material familial, fi-
13
nancial, or professional relationship with 
14
such a party; and 
15
‘‘(iii) not otherwise have a conflict of 
16
interest with such a party (as determined 
17
under regulations). 
18
‘‘(B) EXCEPTION.—Nothing in subpara-
19
graph (A) shall be construed to— 
20
‘‘(i) prohibit an individual, solely on 
21
the basis of affiliation with the issuer, 
22
from serving as an independent medical re-
23
viewer if— 
24
23:00 Jan 11, 2021
H32
23 
•HR 32 IH
‘‘(I) a non-affiliated individual is 
1
not reasonably available; 
2
‘‘(II) the affiliated individual is 
3
not involved in the provision of items 
4
or services in the case under review; 
5
‘‘(III) the fact of such an affili-
6
ation is disclosed to the issuer and the 
7
enrollee (or authorized representative) 
8
and neither party objects; and 
9
‘‘(IV) the affiliated individual is 
10
not an employee of the issuer and 
11
does not provide services exclusively or 
12
primarily to or on behalf of the issuer; 
13
‘‘(ii) prohibit an individual who has 
14
staff privileges at the institution where the 
15
treatment involved takes place from serv-
16
ing as an independent medical reviewer 
17
merely on the basis of such affiliation if 
18
the affiliation is disclosed to the issuer and 
19
the enrollee (or authorized representative), 
20
and neither party objects; or 
21
‘‘(iii) prohibit receipt of compensation 
22
by an independent medical reviewer from 
23
an entity if the compensation is provided 
24
consistent with paragraph (6). 
25
23:00 Jan 11, 2021
H32
24 
•HR 32 IH
‘‘(4) PRACTICING HEALTH CARE PROFESSIONAL 
1
IN SAME FIELD.— 
2
‘‘(A) IN
GENERAL.—In a case involving 
3
treatment, or the provision of items or serv-
4
ices— 
5
‘‘(i) by a physician, a reviewer shall be 
6
a practicing physician (allopathic or osteo-
7
pathic) of the same or similar specialty, as 
8
a physician who, acting within the appro-
9
priate scope of practice within the State in 
10
which the service is provided or rendered, 
11
typically treats the condition, makes the 
12
diagnosis, or provides the type of treat-
13
ment under review; or 
14
‘‘(ii) by a non-physician health care 
15
professional, the reviewer, or at least 1 
16
member of the review panel, shall be a 
17
practicing non-physician health care pro-
18
fessional of the same or similar specialty 
19
as the non-physician health care profes-
20
sional who, acting within the appropriate 
21
scope of practice within the State in which 
22
the service is provided or rendered, typi-
23
cally treats the condition, makes the diag-
24
23:00 Jan 11, 2021
H32
25 
•HR 32 IH
nosis, or provides the type of treatment 
1
under review. 
2
‘‘(B) PRACTICING
DEFINED.—For pur-
3
poses of this paragraph, the term ‘practicing’ 
4
means, with respect to an individual who is a 
5
physician or other health care professional, that 
6
the individual provides health care services to 
7
individual patients on average at least 2 days 
8
per week. 
9
‘‘(5) PEDIATRIC EXPERTISE.—In the case of an 
10
external review relating to a child, a reviewer shall 
11
have expertise under paragraph (2) in pediatrics. 
12
‘‘(6) LIMITATIONS
ON
REVIEWER
COMPENSA-
13
TION.—Compensation provided by the issuer to an 
14
independent medical reviewer in connection with a 
15
review under this section shall— 
16
‘‘(A) not exceed a reasonable level; and 
17
‘‘(B) not be contingent on the decision ren-
18
dered by the reviewer. 
19
‘‘(7) RELATED PARTY DEFINED.—For purposes 
20
of this section, the term ‘related party’ means, with 
21
respect to a denial of a claim under a coverage relat-
22
ing to an enrollee, any of the following: 
23
‘‘(A) The issuer involved, or any fiduciary, 
24
officer, director, or employee of the issuer. 
25
23:00 Jan 11, 2021
H32
26 
•HR 32 IH
‘‘(B) The enrollee (or authorized represent-
1
ative). 
2
‘‘(C) The health care professional that pro-
3
vides the items or services involved in the de-
4
nial. 
5
‘‘(D) The institution at which the items or 
6
services (or treatment) involved in the denial 
7
are provided. 
8
‘‘(E) The manufacturer of any drug or 
9
other item that is included in the items or serv-
10
ices involved in the denial. 
11
‘‘(F) Any other party determined under 
12
any regulations to have a substantial interest in 
13
the denial involved. 
14
‘‘(8) DEFINITIONS.—For purposes of this sub-
15
section: 
16
‘‘(A) ENROLLEE.—The term ‘enrollee’ 
17
means, with respect to health insurance cov-
18
erage offered by a health insurance issuer, an 
19
individual enrolled with the issuer to receive 
20
such coverage. 
21
‘‘(B) HEALTH CARE PROFESSIONAL.—The 
22
term ‘health care professional’ means an indi-
23
vidual who is licensed, accredited, or certified 
24
under State law to provide specified health care 
25
23:00 Jan 11, 2021
H32
27 
•HR 32 IH
services and who is operating within the scope 
1
of such licensure, accreditation, or certification. 
2
‘‘SEC. 2799. ENFORCEMENT. 
3
‘‘(a) IN GENERAL.—Subject to subsection (b), with 
4
respect to specific individual health insurance coverage the 
5
primary State for such coverage has sole jurisdiction to 
6
enforce the primary State’s covered laws in the primary 
7
State and any secondary State. 
8
‘‘(b) SECONDARY STATE’S AUTHORITY.—Nothing in 
9
subsection (a) shall be construed to affect the authority 
10
of a secondary State to enforce its laws as set forth in 
11
the exception specified in section 2796(b)(1). 
12
‘‘(c) COURT INTERPRETATION.—In reviewing action 
13
initiated by the applicable secondary State authority, the 
14
court of competent jurisdiction shall apply the covered 
15
laws of the primary State. 
16
‘‘(d) NOTICE OF COMPLIANCE FAILURE.—In the case 
17
of individual health insurance coverage offered in a sec-
18
ondary State that fails to comply with the covered laws 
19
of the primary State, the applicable State authority of the 
20
secondary State may notify the applicable State authority 
21
of the primary State.’’. 
22
(b) EFFECTIVE DATE.—The amendment made by 
23
subsection (a) shall apply to individual health insurance 
24
23:00 Jan 11, 2021
H32
28 
•HR 32 IH
coverage offered, issued, or sold on or after October 1, 
1
2021. 
2
(c) GAO ONGOING STUDY AND REPORTS.— 
3
(1) STUDY.—The Comptroller General of the 
4
United States shall conduct an ongoing study con-
5
cerning the effect of the amendment made by sub-
6
section (a) on— 
7
(A) the number of uninsured and under-in-
8
sured; 
9
(B) the availability and cost of health in-
10
surance policies for individuals with pre-existing 
11
medical conditions; 
12
(C) the availability and cost of health in-
13
surance policies generally; 
14
(D) the elimination or reduction of dif-
15
ferent types of benefits under health insurance 
16
policies offered in different States; and 
17
(E) cases of fraud or abuse relating to 
18
health insurance coverage offered under such 
19
amendment and the resolution of such cases. 
20
(2) ANNUAL REPORTS.—The Comptroller Gen-
21
eral shall submit to Congress an annual report, after 
22
the end of each of the 5 years following the effective 
23
23:00 Jan 11, 2021
H32
29 
•HR 32 IH
date of the amendment made by subsection (a), on 
1
the ongoing study conducted under paragraph (1). 
2
Æ 
23:00 Jan 11, 2021
H32
